Over ons

We believe Cells can theoretically produce almost anything, from fabrics to food, fuel and medicines. Designing cell-factories is hard, but our tools and machine-learning models can make it easier. Our mission is to ultimately help replace traditional farms and factories for a more sustainable world. Jobs: https://jobs.cradle.bio

Website
http://www.cradle.bio
Branche
Biotechnologie
Bedrijfsgrootte
11 - 50 medewerkers
Hoofdkantoor
Amsterdam
Type
Particuliere onderneming
Opgericht
2021
Specialismen
protein design, machine learning, protein activity, protein stability, protein secretability, protein , protein structure, metabolic engineering, protein engineering en protein solubility

Locaties

Medewerkers van Cradle

Updates

  • Organisatiepagina weergeven voor Cradle, afbeelding

    10.126 volgers

    Congratulations to David Baker, Demis Hassabis and John Jumper for winning the Nobel Prize in Chemistry! Their groundbreaking work has inspired many of us to pursue careers in protein engineering and computational biology, and have opened up new frontiers in drug discovery and biotech. Thank you!

    Organisatiepagina weergeven voor The Nobel Prize, afbeelding

    867.398 volgers

    BREAKING NEWS The Royal Swedish Academy of Sciences has decided to award the 2024 Nobel Prize in Chemistry with one half to David Baker “for computational protein design” and the other half jointly to Demis Hassabis and John M. Jumper “for protein structure prediction.”   The Nobel Prize in Chemistry 2024 is about proteins, life’s ingenious chemical tools. David Baker has succeeded with the almost impossible feat of building entirely new kinds of proteins. Demis Hassabis and John Jumper have developed an AI model to solve a 50-year-old problem: predicting proteins’ complex structures. These discoveries hold enormous potential.   The diversity of life testifies to proteins’ amazing capacity as chemical tools. They control and drive all the chemical reactions that together are the basis of life. Proteins also function as hormones, signal substances, antibodies and the building blocks of different tissues.   Proteins generally consist of 20 different amino acids, which can be described as life’s building blocks. In 2003, David Baker succeeded in using these blocks to design a new protein that was unlike any other protein. Since then, his research group has produced one imaginative protein creation after another, including proteins that can be used as pharmaceuticals, vaccines, nanomaterials and tiny sensors.   The second discovery concerns the prediction of protein structures. In proteins, amino acids are linked together in long strings that fold up to make a three-dimensional structure, which is decisive for the protein’s function. Since the 1970s, researchers had tried to predict protein structures from amino acid sequences, but this was notoriously difficult. However, four years ago, there was a stunning breakthrough.   In 2020, Demis Hassabis and John Jumper presented an AI model called AlphaFold2. With its help, they have been able to predict the structure of virtually all the 200 million proteins that researchers have identified. Since their breakthrough, AlphaFold2 has been used by more than two million people from 190 countries. Among a myriad of scientific applications, researchers can now better understand antibiotic resistance and create images of enzymes that can decompose plastic.   Life could not exist without proteins. That we can now predict protein structures and design our own proteins confers the greatest benefit to humankind. Learn more Press release: https://bit.ly/3TM8oVs Popular information: https://bit.ly/3XYHZGp Advanced information: https://bit.ly/4ewMBta

    • Geen alternatieve tekst opgegeven voor deze afbeelding
  • Organisatiepagina weergeven voor Cradle, afbeelding

    10.126 volgers

    We are happy to announce that we are partnering with iGEM Community for the iGEM Competition. As sponsors, we're supporting iGEM's global platform for synthetic biology education and innovation. The iGEM Competition encourages students to develop innovative solutions to real-world problems using synthetic biology. We believe that AI will significantly accelerate progress in this field, and we're keen to see the creative approaches that participants will bring to the competition. Our team members, Daan and Michelle, will be attending the 2024 iGEM Grand Jamboree in Paris from October 23-25, and they are excited to share our strategies and learnings from the lab with the iGEM community, and particularly share how we're using AI to accelerate protein design. They will give a presentation on how to use automated high-throughput workflows in your own lab on Friday, October 25th at 12:45 CEST. Stop by our booth if you want to try your hand at your own protein designs, and see how they size up against our models!

    • Geen alternatieve tekst opgegeven voor deze afbeelding
  • Cradle heeft dit gerepost

    Profiel weergeven voor Stef van Grieken, afbeelding

    Co-founder & CEO - We're hiring!

    We compared our AI platform to the winners of the Align to Innovate tournament. This tournament was designed to benchmark the latest computational methods in enzyme engineering, in scenarios that closely mimic real-world challenges, and featured over 30 teams from industry and academia. While we did not participate in the tournament at the time, we were recently asked by a potential customer to run the benchmark to see how we would stack up – and we're proud of the results! Across the four supervised enzyme property prediction challenges, our automatically generated models twice beat first place, and twice tied first place! What makes these results particularly exciting is that we achieved them running our platform in a fully automated fashion, with no human intervention required. Just as a high-end camera can capture stunning photos in auto-mode, our AI platform delivered top-tier performance without any human input required. This showcases the power of our fully automated process, which matched or outperformed methods that typically require extensive custom tuning and feature engineering by experts. While our platform does offer the flexibility for manual adjustments - akin to a DSLR's manual mode allows you to set the shutter-speed etc. - many users find the auto-mode sufficient for most applications. This allows protein engineers to redirect their expertise towards more critical aspects of their work such as target and property selection, structural and functional application of the designs, novel assay development and data analysis to name a few. Read more here: https://lnkd.in/eQDZmccQ

    Cradle – 'Align to Innovate' benchmark: state-of-the-art enzyme engineering with fully-automated GenAI

    Cradle – 'Align to Innovate' benchmark: state-of-the-art enzyme engineering with fully-automated GenAI

    cradle.bio

  • Cradle heeft dit gerepost

    Profiel weergeven voor Wallis MARGRAFF, afbeelding

    Having a stubborn protein? Let's chat | Saas | Protein Engineering | ML/AI | wallis@cradle.bio

    🇨🇭 It's not all about CDRs. Discover how #ML-guided protein design is breaking boundaries by optimizing binding affinity, expression, and stability in surprising ways. 👇 Daniel Danciu will share insights on how even significant #CDR modifications—including CDR3—can retain strong binding properties when driven by a custom-conditioned #protein language model. Plus, learn how active-learning can supercharge antibody optimization from early-stage leads. 𝐖𝐡𝐞𝐧? October 9th at 12:45 👑 Franziska Geiger, Jonathan D. Ziegler & myself are looking forward to seeing you there & answer any questions 😎 Cradle x BioTechX

  • Organisatiepagina weergeven voor Cradle, afbeelding

    10.126 volgers

    Cradle will attend Biologics US in San Diego next week, Oct 3rd and 4th. 🎤 Join Eli Bixby (Co-Founder, Head of ML) when he presents Cradle’s active learning approach for antibody optimization. Friday at 12:25 🤓 Nerd out about multi-property, multi-stage generative protein design with ML Researcher Patrick Kidger. ☕ If you are interested in using Cradle to speed up your protein design process, ping Sam Partovi! #BIOLOGICS #SanDiego #proteindesign #ML #conference

    • Geen alternatieve tekst opgegeven voor deze afbeelding
    • Geen alternatieve tekst opgegeven voor deze afbeelding
  • Organisatiepagina weergeven voor Cradle, afbeelding

    10.126 volgers

    We are very excited to welcome Sam Partovi as our new Chief Commercial Officer at Cradle! Sam brings over two decades of experience in scaling cloud-based platforms for the life sciences industry. He has built go-to-market teams at leading companies including Medidata, Benchling, and Veeva Systems. Sam's expertise in using technology to speed up scientific progress fits perfectly with our mission. Sam joins Cradle at an important time in our growth. Since our launch in 2022, we've seen strong interest in our platform, which has helped customers achieve up to 12x faster development times for therapeutics, diagnostics, chemical, food, and agricultural proteins. With Sam on our team, we're ready to reach more scientists. Welcome to Cradle, Sam!

    Profiel weergeven voor Sam Partovi, afbeelding

    GTM Executive - Technology Platforms for Life Sciences.

    I'm truly excited to join Cradle as Chief Commercial Officer! The team's innovative work in AI-powered protein design is not just impressive—it's transformative. Cradle's mission to accelerate scientific progress through more efficient protein engineering resonates strongly with my passion for advancing life sciences technology. Cradle is at the forefront of the bio+ml transformation and in just the last two years, achieved remarkable results that speak for themselves. Using the platform, customers have reduced development timelines significantly, with impressive accelerations ranging from 1.5x to 12x across various projects and therapeutic modalities. It's energizing to see Cradle deliver real scientific and business outcomes across biopharmaceutical, agriculture, chemical and food technologies. I'm excited and humbled to work alongside this talented team in enabling the industry to push the boundaries of what's possible! Follow Cradle and see what we're up to! #Cradle

    • Geen alternatieve tekst opgegeven voor deze afbeelding
  • Organisatiepagina weergeven voor Cradle, afbeelding

    10.126 volgers

    We are proud that we continue to be recognised as one of the key innovators. Whether that is as a startup in Europe, or more locally in Switzerland or The Netherlands, or on a global scale in the AI x Healthcare or Biology sector. IVP listed us as one of 35 companies to watch. swissICT calls us the Next Global Hot Thing in AI, and in The Netherlands we are nominated for the Computable.nl Awards ❤️ For that last one, we could really use your vote https://lnkd.in/dEaURW7U 🔥

    • Geen alternatieve tekst opgegeven voor deze afbeelding
    • Geen alternatieve tekst opgegeven voor deze afbeelding
    • Geen alternatieve tekst opgegeven voor deze afbeelding
  • Cradle heeft dit gerepost

    Profiel weergeven voor Wallis MARGRAFF, afbeelding

    Having a stubborn protein? Let's chat | Saas | Protein Engineering | ML/AI | wallis@cradle.bio

    Harmen van Rossum will be speaking at the Bio-Technopark in Schlieren-Zürich on how we're using generative #AI for designing better proteins. Details? 👇 👀 𝐖𝐡𝐞𝐧? 1st of October : 16h15   📍 𝐖𝐡𝐞𝐫𝐞? Wagistrasse 25, 8952 #Schlieren at the Auditorium, EG 🎉 No registration required  ✨ 𝑭𝒓𝒆𝒆 of attendance  🍻 Followed by *𝒇𝒓𝒆𝒆* networking drinks Join us! He will also cover how we use automation and high-throughput methods in our lab to rapidly iterate on our #ML models.

    • Geen alternatieve tekst opgegeven voor deze afbeelding

Vergelijkbare pagina’s

Door vacatures bladeren

Financiering

Cradle 2 rondes in totaal

Laatste ronde

Serie A

US$ 24.000.000,00

Bekijk meer informatie over Crunchbase